What is the evidence for AOD-9604?
AOD-9604 is a useful example of why preclinical promise is not enough: substantial human development did not produce persuasive efficacy or an approved obesity indication.
DIRECT ANSWER
AOD-9604 evidence summary.
AOD-9604 is a useful example of why preclinical promise is not enough: substantial human development did not produce persuasive efficacy or an approved obesity indication.
Reviewed August 8, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
A sizable randomized phase 2 obesity program was conducted, but FDA's review notes the results did not support commercial development.
Open evidence recordPreclinical lipolysis and weight-related signals did not translate into an approved obesity medicine.
Open evidence recordThe existence of a large trial should not be summarized as positive evidence when the development result was not clinically persuasive.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
3 source records, with duplicates removed.